Boyle BM, Kappelman MD, Colletti RB, Baldassano RN, Milov DE, Crandall WV (2014). Routine use of tiopurines in maintaining remission in pediatric Crohn's disease.  World Journal Gastroenterology 20(27), pg. 9185-90.

The multi-center Pediatric Inflammatory Bowel Disease Network (PIBDNet) cohort study prospectively collected data on thiopurine naïve patients initiating mercaptopurine (6MP) or azathioprine. Patients with a diagnosis of Crohn’s disease (CD) were included in our study upon entering remission as determined by physician global assessment (PGA) within 365 d of initiation of thiopurines.

Read more

Built by Veracity Media on NationBuilder